Winlevi drug

Although acne is the most common skin condition in the United States, the last FDA approval for acne medication with a new mechanism of action occurred almost 40 years ago. Acne is a multifactorial skin condition that is affected by four specific pathways: Excess oil production (sebum) Clogged pores (hyperkeratinization) […]

Sogroya (Sumapacitan)

The US Food and Drug Administration (FDA) has approved the drug Sogroya (Sumapacitan) for adults with growth hormone deficiency. Sogroya is the first human growth hormone treatment performed by adult patients only once a week by subcutaneous injection. Other FDA-approved human growth hormone formulations for adults with growth hormone deficiency should be prescribed daily. […]